Related Experiment Video
Updated: Jul 8, 2026
08:41
Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
Published on: October 27, 2014
Recent developments in taxane drug delivery.
1Department of Radiation Oncology and the Comprehensive Cancer Center, University of Alabama at Birmingham, 6th Avenue South, Birmingham, AL 35294-6832, USA. Safavy@uab.edu
Current Drug Delivery
|January 29, 2008
Summary
Researchers are developing advanced taxane delivery systems to enhance antitumor activity and reduce toxicity. These innovative methods include targeted therapies and novel nanostructures for improved cancer treatment.
Area of Science:
- Oncology
- Pharmacology
- Nanotechnology
Background:
- Paclitaxel and docetaxel are crucial antitumor drugs in cancer management.
- Ongoing research aims to improve their efficacy and reduce systemic toxicity.
- Physical and chemical strategies are explored to enhance antitumor activity and minimize side effects.
Purpose of the Study:
- To review recent advancements in taxane delivery systems.
- To focus on tumor cell surface receptor-targeted delivery mechanisms.
- To explore non-targeted delivery approaches for taxanes.
Main Methods:
- Review of recent literature on taxane delivery systems.
- Analysis of targeted delivery using small-molecule peptides and monoclonal antibodies.
- Evaluation of non-targeted methods including liposomes, nanostructures, and polymers.
Main Results:
- Development of targeted taxane delivery systems utilizing specific molecular ligands.
- Exploration of various nanocarriers like liposomes and polymeric nanoparticles for drug delivery.
- Investigation of natural and synthetic polymers for enhanced drug formulation.
Conclusions:
- Advanced taxane delivery systems show promise for improved cancer therapy.
- Targeted delivery mechanisms offer potential for increased efficacy and reduced side effects.
- Nanotechnology and polymer science are key to developing next-generation taxane formulations.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...